Fundraising Fox
Radionetics
San Diego, US · Founded 2021 · 49 employees on LinkedIn · 3 known investors
Find your way into Radionetics
Sign up to see every warm intro you have to Radionetics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Radionetics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.
Founders & leadership
Radionetics was founded in 2021 by Brett Ewald.
Investors · 3
How we know: 5AM Ventures's portfolio page · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Founder mafia
3 people who came through Radionetics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Radionetics do?
- Radionetics develops small molecule radiopharmaceuticals targeting GPCRs for cancer therapy and diagnosis, using a precision medicine approach that combines radioisotopes with potent, selective ligands. The company is headquartered in San Diego, California, and focuses on theranostic applications in oncology.
- Who founded Radionetics?
- Radionetics was founded by Brett Ewald in 2021.
- Who are Radionetics's investors?
- Radionetics's investors include 5AM Ventures, Frazier Life Sciences, DCVC Bio.
- Where is Radionetics headquartered?
- Radionetics is headquartered in San Diego, US.